The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease

Abstract:Fabry disease is a rare X-linked lysosomal storage disorder caused by deficient activity of α-galactosidase A (α-Gal A) resulting in the storage of glycosphingolipids, especially globotriaosylceramide (Gb3), in cells throughout the body, causing life-threatening renal, cardiac, and cerebrov...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gupta, Surya N. (VerfasserIn) , Ries, Markus (VerfasserIn) , Kotsopoulos, Steven (VerfasserIn) , Schiffmann, Raphael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2005/09/01
In: Medicine
Year: 2005, Jahrgang: 84, Heft: 5, Pages: 261-268
ISSN:1536-5964
DOI:10.1097/01.md.0000178976.62537.6b
Online-Zugang:Verlag, Volltext: https://doi.org/10.1097/01.md.0000178976.62537.6b
Volltext
Verfasserangaben:Surya Gupta, MD, Markus Ries, MD, MHSc, Steven Kotsopoulos, BS, and Raphael Schiffmann, MD
Beschreibung
Zusammenfassung:Abstract:Fabry disease is a rare X-linked lysosomal storage disorder caused by deficient activity of α-galactosidase A (α-Gal A) resulting in the storage of glycosphingolipids, especially globotriaosylceramide (Gb3), in cells throughout the body, causing life-threatening renal, cardiac, and cerebrov
Beschreibung:Gesehen am 16.05.2019
Beschreibung:Online Resource
ISSN:1536-5964
DOI:10.1097/01.md.0000178976.62537.6b